Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis.

ABSTRACT:

Background

Tuberculosis remains a serious world-wide health threat which requires the characterisation of novel drug targets for the development of future antimycobacterials. One of the key obstacles in the definition of new targets is the large variety of metabolic alterations that occur between cells in the active growth and chronic/dormant phases of tuberculosis. The ideal biochemical target should be active in both growth phases. Methionine adenosyltransferase, which catalyses the formation of S-adenosylmethionine from methionine and ATP, is involved in polyamine biosynthesis during active growth and is also required for the methylation and cyclopropylation of mycolipids necessary for survival in the chronic phase.

Results

The gene encoding methionine adenosyltransferase

SUBMITTER: Berger BJ 

PROVIDER: S-EPMC165446 | biostudies-literature | 2003 Jun

REPOSITORIES: biostudies-literature